Trexquant Investment LP Teva Pharmaceutical Industries LTD Transaction History

Trexquant Investment LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $790,915 - $1.08 Million	-61,887 Reduced 16.31%	317,446 $5.16 Million
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $4.05 Million - $5.47 Million	379,333 New	379,333 $5.35 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $2.31 Million - $3.14 Million	276,500 New	276,500 $2.45 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $907,975 - $1.58 Million	132,358 Added 108.67%	254,152 $2.05 Million
Q2 2022 Aug 11, 2022	BUY	$7.38 - $10.4 $778,966 - $1.1 Million	105,551 Added 649.82%	121,794 $916,000
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $119,061 - $152,521	16,243 New	16,243 $153,000
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $1.14 Million - $1.39 Million	-136,109 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$9.9 - $11.56 $1.24 Million - $1.44 Million	124,753 Added 1098.56%	136,109 $1.35 Million
Q1 2021 May 13, 2021	BUY	$10.34 - $12.81 $117,421 - $145,470	11,356 New	11,356 $131,000
Q2 2020 Aug 07, 2020	SELL	$8.12 - $13.12 $2.17 Million - $3.51 Million	-267,151 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$6.69 - $13.45 $1.79 Million - $3.59 Million	267,151 New	267,151 $2.4 Million
Q1 2019 May 13, 2019	SELL	$15.58 - $20.01 $3.64 Million - $4.67 Million	-233,335 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$14.59 - $23.84 $3.4 Million - $5.56 Million	233,335 New	233,335 $3.6 Million
Q3 2018 Nov 09, 2018	SELL	$21.06 - $25.65 $1.64 Million - $1.99 Million	-77,691 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$16.77 - $24.71 $1.3 Million - $1.92 Million	77,691 New	77,691 $1.89 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.